Prenetics Global Limited Class A Ordinary Share
Symbol: PRE (NASDAQ)
9.50
▲ (7.22%) 0.640
Company Description:
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
Key Stats
- Today's Open: $9.154
- Today's High: $9.5
- Today's Low: $9.154
- Today's Volume: 22
- Yesterday Close: $8.86
- Yesterday High: $10.5
- Yesterday Low: $8.2
- Yesterday Volume: 229.57K
- Last Min Volume: 0
- Last Min High: $9.5
- Last Min Low: $9.499
- Last Min VWAP: $0
Company Profile
- Name: Prenetics Global Limited Class A Ordinary Share
- Website: https://www.prenetics.com
- Listed Date: 2022-05-18
- Location: ,
- Market Status: Active
- CIK Number: 0001876431
- SIC Code:
- SIC description:
- Market Cap: $131.38M
- Round Lot: 100
- Outstanding Shares: 13.03M
- Asset Type: CS
RECENT FILINGS FOR PRE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | EFFECT | View |
| 2025-09-08 | F-3/A | View |
| 2025-08-22 | F-3/A | View |
| 2025-08-22 | 6-K | View |
| 2025-08-22 | 6-K/A | View |
| 2025-08-07 | 6-K/A | View |
| 2025-08-01 | 6-K | View |
| 2025-07-22 | F-3 | View |
| 2025-07-18 | 20-F/A | View |
| 2025-07-18 | 6-K | View |
| 2025-07-17 | 6-K | View |
| 2025-06-18 | 6-K | View |
| 2025-06-18 | 6-K | View |
| 2025-06-16 | 6-K | View |
| 2025-06-12 | 6-K/A | View |
| 2025-06-12 | 6-K | View |
| 2025-05-29 | 6-K | View |
| 2025-05-07 | S-8 | View |
| 2025-04-30 | 20-F | View |
| 2025-03-05 | 6-K | View |
Latest News on PRE